A citation-based method for searching scientific literature

Yuchen Jiao, Chanjuan Shi, Barish H Edil, Roeland F de Wilde, David S Klimstra, Anirban Maitra, Richard D Schulick, Laura H Tang, Christopher L Wolfgang, Michael A Choti, Victor E Velculescu, Luis A Diaz, Bert Vogelstein, Kenneth W Kinzler, Ralph H Hruban, Nickolas Papadopoulos. Science 2011
Times Cited: 1045







List of co-cited articles
971 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Whole-genome landscape of pancreatic neuroendocrine tumours.
Aldo Scarpa, David K Chang, Katia Nones, Vincenzo Corbo, Ann-Marie Patch, Peter Bailey, Rita T Lawlor, Amber L Johns, David K Miller, Andrea Mafficini,[...]. Nature 2017
358
47

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Arvind Dasari, Chan Shen, Daniel Halperin, Bo Zhao, Shouhao Zhou, Ying Xu, Tina Shih, James C Yao. JAMA Oncol 2017
915
29

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
Shinichi Yachida, Efsevia Vakiani, Catherine M White, Yi Zhong, Tyler Saunders, Richard Morgan, Roeland F de Wilde, Anirban Maitra, Jessica Hicks, Angelo M Demarzo,[...]. Am J Surg Pathol 2012
272
26

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
James C Yao, Manal Hassan, Alexandria Phan, Cecile Dagohoy, Colleen Leary, Jeannette E Mares, Eddie K Abdalla, Jason B Fleming, Jean-Nicolas Vauthey, Asif Rashid,[...]. J Clin Oncol 2008
23

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
623
20

Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Ilaria Marinoni, Anja Schmitt Kurrer, Erik Vassella, Matthias Dettmer, Thomas Rudolph, Vanessa Banz, Fabio Hunger, Silvan Pasquinelli, Ernst-Jan Speel, Aurel Perren. Gastroenterology 2014
220
20

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup.
Chang S Chan, Saurabh V Laddha, Peter W Lewis, Matthew S Koletsky, Kenneth Robzyk, Edaise Da Silva, Paula J Torres, Brian R Untch, Janet Li, Promita Bose,[...]. Nat Commun 2018
55
36

Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors.
Aatur D Singhi, Ta-Chiang Liu, Justin L Roncaioli, Dengfeng Cao, Herbert J Zeh, Amer H Zureikat, Allan Tsung, J Wallis Marsh, Kenneth K Lee, Melissa E Hogg,[...]. Clin Cancer Res 2017
96
18

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.
Guido Rindi, David S Klimstra, Behnoush Abedi-Ardekani, Sylvia L Asa, Frederik T Bosman, Elisabeth Brambilla, Klaus J Busam, Ronald R de Krijger, Manfred Dietel, Adel K El-Naggar,[...]. Mod Pathol 2018
252
18

Everolimus for advanced pancreatic neuroendocrine tumors.
James C Yao, Manisha H Shah, Tetsuhide Ito, Catherine Lombard Bohas, Edward M Wolin, Eric Van Cutsem, Timothy J Hobday, Takuji Okusaka, Jaume Capdevila, Elisabeth G E de Vries,[...]. N Engl J Med 2011
16

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
M Falconi, B Eriksson, G Kaltsas, D K Bartsch, J Capdevila, M Caplin, B Kos-Kudla, D Kwekkeboom, G Rindi, G Klöppel,[...]. Neuroendocrinology 2016
481
15

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Jonathan Strosberg, Ghassan El-Haddad, Edward Wolin, Andrew Hendifar, James Yao, Beth Chasen, Erik Mittra, Pamela L Kunz, Matthew H Kulke, Heather Jacene,[...]. N Engl J Med 2017
15

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.
Edoardo Missiaglia, Irene Dalai, Stefano Barbi, Stefania Beghelli, Massimo Falconi, Marco della Peruta, Lorenzo Piemonti, Gabriele Capurso, Alessia Di Florio, Gianfranco delle Fave,[...]. J Clin Oncol 2010
367
14

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
Eric Raymond, Laetitia Dahan, Jean-Luc Raoul, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Juan Valle, Peter Metrakos, Denis Smith, Aaron Vinik,[...]. N Engl J Med 2011
14

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.
James C Yao, Nicola Fazio, Simron Singh, Roberto Buzzoni, Carlo Carnaghi, Edward Wolin, Jiri Tomasek, Markus Raderer, Harald Lahner, Maurizio Voi,[...]. Lancet 2016
535
14

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.
H Sorbye, S Welin, S W Langer, L W Vestermark, N Holt, P Osterlund, S Dueland, E Hofsli, M G Guren, K Ohrling,[...]. Ann Oncol 2013
444
14

Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Martyn E Caplin, Marianne Pavel, Jarosław B Ćwikła, Alexandria T Phan, Markus Raderer, Eva Sedláčková, Guillaume Cadiot, Edward M Wolin, Jaume Capdevila, Lucy Wall,[...]. N Engl J Med 2014
824
14

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.
Paloma Cejas, Yotam Drier, Koen M A Dreijerink, Lodewijk A A Brosens, Vikram Deshpande, Charles B Epstein, Elfi B Conemans, Folkert H M Morsink, Mindy K Graham, Gerlof D Valk,[...]. Nat Med 2019
49
28

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
Anja Rinke, Hans-Helge Müller, Carmen Schade-Brittinger, Klaus-Jochen Klose, Peter Barth, Matthias Wied, Christina Mayer, Behnaz Aminossadati, Ulrich-Frank Pape, Michael Bläker,[...]. J Clin Oncol 2009
13


ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
R Garcia-Carbonero, H Sorbye, E Baudin, E Raymond, B Wiedenmann, B Niederle, E Sedlackova, C Toumpanakis, M Anlauf, J B Cwikla,[...]. Neuroendocrinology 2016
215
12

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Joshua M Francis, Adam Kiezun, Alex H Ramos, Stefano Serra, Chandra Sekhar Pedamallu, Zhi Rong Qian, Michaela S Banck, Rahul Kanwar, Amit A Kulkarni, Anna Karpathakis,[...]. Nat Genet 2013
181
12

DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.
Joo Kyung Park, Woo Hyun Paik, Kyoungbun Lee, Ji Kon Ryu, Sang Hyub Lee, Yong-Tae Kim. Oncotarget 2017
32
37

Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases.
Antonio Pea, Jun Yu, Luigi Marchionni, Michael Noe, Claudio Luchini, Alessandra Pulvirenti, Roeland F de Wilde, Lodewijk A Brosens, Neda Rezaee, Ammar Javed,[...]. Ann Surg 2020
35
34

The 2019 WHO classification of tumours of the digestive system.
Iris D Nagtegaal, Robert D Odze, David Klimstra, Valerie Paradis, Massimo Rugge, Peter Schirmacher, Kay M Washington, Fatima Carneiro, Ian A Cree. Histopathology 2020
377
12

Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3.
Björn Konukiewitz, Moritz Jesinghaus, Katja Steiger, Anna Melissa Schlitter, Atsuko Kasajima, Bence Sipos, Giuseppe Zamboni, Wilko Weichert, Nicole Pfarr, Günter Klöppel. Hum Pathol 2018
32
34

Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study.
Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno, Masayuki Furukawa, Hideyuki Yoshitomi, Noritoshi Kobayashi, Masafumi Ikeda, Tetsuhide Ito, Shoji Nakamori,[...]. Clin Cancer Res 2017
70
15

Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
Joo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, Sung Joo Kim, Ki-Byung Song, Min-Sun Kim, Mi-Ju Kim, Dae Wook Hwang, Alan K Meeker, Eunsil Yu,[...]. Clin Cancer Res 2017
57
19

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.
Peter W Lewis, Simon J Elsaesser, Kyung-Min Noh, Sonja C Stadler, C David Allis. Proc Natl Acad Sci U S A 2010
486
11

The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Olca Basturk, Zhaohai Yang, Laura H Tang, Ralph H Hruban, Volkan Adsay, Chad M McCall, Alyssa M Krasinskas, Kee-Taek Jang, Wendy L Frankel, Serdar Balci,[...]. Am J Surg Pathol 2015
242
11

Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.
Xiafei Hong, Sitan Qiao, Fuqiang Li, Wenze Wang, Rui Jiang, Huanwen Wu, Hao Chen, Lulu Liu, Junya Peng, Jing Wang,[...]. Gut 2020
21
47

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study.
Namrata Vijayvergia, Patrick M Boland, Elizabeth Handorf, Karen S Gustafson, Yulan Gong, Harry S Cooper, Fathima Sheriff, Igor Astsaturov, Steven J Cohen, Paul F Engstrom. Br J Cancer 2016
53
18

Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.
Somak Roy, William A LaFramboise, Ta-Chiang Liu, Dengfeng Cao, Alyssa Luvison, Caitlyn Miller, Maureen A Lyons, Roderick J O'Sullivan, Amer H Zureikat, Melissa E Hogg,[...]. Gastroenterology 2018
31
32

ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells.
Lee H Wong, James D McGhie, Marcus Sim, Melissa A Anderson, Soyeon Ahn, Ross D Hannan, Amee J George, Kylie A Morgan, Jeffrey R Mann, K H Andy Choo. Genome Res 2010
258
9

Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
Anna Karpathakis, Harpreet Dibra, Chistodoulos Pipinikas, Andrew Feber, Tiffany Morris, Joshua Francis, Dahmane Oukrif, Dalvinder Mandair, Marinos Pericleous, Mullan Mohmaduvesh,[...]. Clin Cancer Res 2016
86
10


Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
9

Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
David Clynes, Clare Jelinska, Barbara Xella, Helena Ayyub, Caroline Scott, Matthew Mitson, Stephen Taylor, Douglas R Higgs, Richard J Gibbons. Nat Commun 2015
128
9


Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.
Amit Tirosh, Sanjit Mukherjee, Justin Lack, Sudheer Kumar Gara, Sophie Wang, Martha M Quezado, Xavier M Keutgen, Xiaolin Wu, Maggie Cam, Suresh Kumar,[...]. Cancer 2019
17
52

Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Laura H Tang, Brian R Untch, Diane L Reidy, Eileen O'Reilly, Deepti Dhall, Lily Jih, Olca Basturk, Peter J Allen, David S Klimstra. Clin Cancer Res 2016
145
9

Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability.
Nitya Raj, Ronak Shah, Zsofia Stadler, Semanti Mukherjee, Joanne Chou, Brian Untch, Janet Li, Virginia Kelly, Leonard B Saltz, Diana Mandelker,[...]. JCO Precis Oncol 2018
22
40

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.
M Heetfeld, C N Chougnet, I H Olsen, A Rinke, I Borbath, G Crespo, J Barriuso, M Pavel, D O'Toole, T Walter. Endocr Relat Cancer 2015
166
9

First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.
Jonathan R Strosberg, Robert L Fine, Junsung Choi, Aejaz Nasir, Domenico Coppola, Dung-Tsa Chen, James Helm, Larry Kvols. Cancer 2011
452
8

The epidemiology of gastroenteropancreatic neuroendocrine tumors.
Ben Lawrence, Bjorn I Gustafsson, Anthony Chan, Bernhard Svejda, Mark Kidd, Irvin M Modlin. Endocrinol Metab Clin North Am 2011
501
8

MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Vincenzo Corbo, Irene Dalai, Maria Scardoni, Stefano Barbi, Stefania Beghelli, Samantha Bersani, Luca Albarello, Claudio Doglioni, Christina Schott, Paola Capelli,[...]. Endocr Relat Cancer 2010
90
8

Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease.
Irvin M Modlin, Bjorn I Gustafsson, Steven F Moss, Marianne Pavel, Apostolos V Tsolakis, Mark Kidd. Ann Surg Oncol 2010
227
8

A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.
Anguraj Sadanandam, Stephan Wullschleger, Costas A Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, Jan Körner, Ismael Wafy, Andrea Mafficini, Rita T Lawlor,[...]. Cancer Discov 2015
78
10

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
342
8

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.
M Pavel, D O'Toole, F Costa, J Capdevila, D Gross, R Kianmanesh, E Krenning, U Knigge, R Salazar, U-F Pape,[...]. Neuroendocrinology 2016
435
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.